Experts from home and abroad gather at Taiwan Digestive Medicine Week to highlight CBM's critical cancer auxiliary services
On the opening day of the annual “Taiwan Digestive Medicine Week”, an authoritative person went to Taiwan to talk about the “2 major trends” in severe cancer treatment.
The annual Taiwan Digestive Medicine Week (2023 TDDW) was grandly launched at National Sun Yat-sen University in Kaohsiung. TDDW is a world-renowned medical seminar. This time it also brings together digestive medicine experts from all over the world to showcase the latest medical knowledge and new technologies. Among them, cancer, severe disease and microbial treatment are important projects of this medical week, and the auxiliary effect of the famous medical strain CBM588 on severe cancer has also become the focus of attention from all walks of life.
The organizer of this event, the Taiwan Gastroenterological Medical Association, specially invited “Professor Masaki Mori”, Dean of Tokai University School of Medicine in Japan (formerly Chairman of the Japanese Society of Surgery and Gastrointestinal Surgery and Vice President of the Japanese Cancer Society), to share unique topics With global new medical technologies and clinical experience, Professor Sen pointed out: “Early cancer detection technology - advanced technology detects cancer cell-related nucleic acids and exosomes in the blood, which can enable early detection and treatment, improve the survival rate and prolong the life of cancer patients.” life."
Another technology that has great potential in the medical field, “telesurgery,” Professor Mori said: “As long as this technology and equipment are available, patients in Hokkaido no longer need to travel thousands of miles and can receive surgery from as far away as Tokyo. “Doctors use robotic arms to perform surgeries.” This advanced robotic arm technology can remotely support other hospitals in real time, share resources and technologies with various places, benefit patients, make medical treatment without geographical restrictions, and shorten the gap between urban and rural areas.
Chemotherapy combined with probiotics is expected to reduce side effects. Will “microbial therapy” become an indicator drug for cancer?
The development of medical treatment is even more rapid. It is no longer limited to general drugs. Microorganisms have also become the key to treatment. In the treatment of cancer and severe diseases, the use of chemical and immunological agents will produce serious side effects on the digestive system, which will affect the patient’s willingness to treat. During cancer treatment, combined with probiotic CBM588, it can alleviate the gastrointestinal side effects caused by changes in gastrointestinal flora. It has become an indicator drug for preventing cancer recurrence and auxiliary anti-cancer drug treatment.
The Japanese research team also found that tumor immunotherapy requires healthy intestinal flora. When patients with non-small cell lung cancer undergo immunotherapy, the use of PPIs will reduce the therapeutic effect. However, if CBM588 is used concurrently, the patient’s therapeutic effect can be improved.
CBM588 probiotics are not affected by antibiotic treatment and are expected to improve clinical cancer treatment effects
A research report published in the American Society of Clinical Oncology (ASCO) Nature Medicine journal pointed out that probiotics can modulate the intestinal microbiome of patients with metastatic renal cell carcinoma treated with immunotherapy and improve clinical treatment outcomes. It is worth mentioning that CBM588 probiotics are not affected by antibiotics and can still grow normally and exert their probiotic effects even under antibiotic treatment. This property is crucial for many cancer patients.
This year’s Taiwan Digestive Medicine Week promotes the sharing of medical knowledge about the intestinal tract from various countries. This academic exchange has the opportunity to improve the treatment effect of severe digestive system diseases, help enough patients to better fight against diseases, and improve survival rates and treatment. Comfort.
Further reading:
